Eos Advisory
Overview
Eos Advisory is an impact investment firm based in St Andrews, Scotland, founded in 2014. The firm invests in and commercializes science and technology companies from seed-stage to global scale, with a focus on improving lives. Eos's investment strategy is centered on four key impact areas: disease diagnosis, prevention, and treatment; energy security and climate change; food and water security; and the sustainability of industrial processes. Initially an angel investment syndicate, the firm scaled in 2021 with the launch of its annual EIS Innovation Fund and works with later-stage Venture Partners. Eos works in long-term partnerships with family offices, individuals, companies, and institutional investors.
Portfolio Companies
14
Website
eos-advisory.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Scarlet Therapeutics | May 2026 | Seed | Lead |
| Bioliberty | Mar 2026 | Series A | Co-investor |
| Neupulse | Feb 2026 | Early Funding | Lead |
| Chemify | Oct 2025 | Series B | Co-investor |
| EnsiliTech | Aug 2025 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.